pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
Published 6 months ago • 106 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
1:28
use of machine learning to predict outcomes for patients with scd
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
3:35
epigenomics in precision oncology
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
4:16
the role of the trop2 biomarker in cancer
-
2:01
the evolution of bcl2 inhibition in cll
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:52
petrea: evaluating pet-adapted maintenance therapy approaches for patients with follicular lymphoma
-
6:04
phase ii evi-2 study: vitamin c supplementation in patients with ccus or lr-mds
-
2:09
heart transplantation in attr amyloidosis
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
2:50
insights into the ca057-003 trial: mezigdomide, tazemetostat & dexamethasone for r/r myeloma
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
1:37
transplantation: a holistic approach
-
1:59
the role of proteasome inhibitors in the treatment of r/r multiple myeloma
-
4:31
labmt: impact of treatment prior to allogenic hct in mds